Cargando…

Culture filtrate proteins from BCG act as adjuvants for cytotoxic T lymphocyte induction

Mycobacterium bovis bacilli Calmette-Guerin (BCG) is a licensed vaccine against tuberculosis. It requires attenuated live bacteria to be effective, possibly because actively secreted proteins play a critical role in inducing anti-tuberculosis immunity. BCG also functions as an effective adjuvant. Mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mizuno, Satoru, Chuma, Yasushi, Shibuya, Yukihiro, Horibata, Shigeo, Baba, Tomoe, Yokokawa, Emi, Matsuo, Kazuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622798/ https://www.ncbi.nlm.nih.gov/pubmed/37928526 http://dx.doi.org/10.3389/fimmu.2023.1271228

Ejemplares similares

The Induction of Antigen 85B-Specific CD8(+) T Cells by Recombinant BCG Protects against Mycobacterial Infection in Mice
por: Komine-Aizawa, Shihoko, et al.
Publicado: (2023)

Recombinant BCG-Prime and DNA-Boost Immunization Confers Mice with Enhanced Protection against Mycobacterium kansasii
por: Komine-Aizawa, Shihoko, et al.
Publicado: (2021)

The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
por: Yamamoto, Kotaro, et al.
Publicado: (2019)

Protection against highly pathogenic SIV by BCG-SIV recombinant priming and attenuated replicating vaccinia-SIV recombinant boosting
por: Zhang, X, et al.
Publicado: (2012)

Proteomic profile of culture filtrate from the Brazilian vaccine strain Mycobacterium bovis BCG Moreau compared to M. bovis BCG Pasteur
por: Berrêdo-Pinho, Marcia, et al.
Publicado: (2011)

Re-reading ACT, BCG, and Low COVID-19 in Africa
por: Kangbai, Jia Bainga, et al.
Publicado: (2021)

The Structural and Functional Organization of the Podocyte Filtration Slits Is Regulated by Tjp1/ZO-1
por: Itoh, Masahiko, et al.
Publicado: (2014)

THE MODIFYING EFFECT OF BCG ON THE IMMUNOLOGICAL INDUCTION OF T CELLS
por: Mackaness, G. B., et al.
Publicado: (1974)

Lipid Nanoparticle Acts as a Potential Adjuvant for Influenza Split Vaccine without Inducing Inflammatory Responses
por: Shirai, Seiki, et al.
Publicado: (2020)

Prognostic value of impaired estimated glomerular filtration rate in intravesical BCG-treated non–muscle-invasive bladder cancer patients
por: Tae, Bum Sik, et al.
Publicado: (2017)

BCG: Disseminated BCG infection: case report
Publicado: (2022)

Recombinant BCG Expressing LTAK63 Adjuvant induces Superior Protection against Mycobacterium tuberculosis
por: Nascimento, Ivan P., et al.
Publicado: (2017)

The Adjuvant Activity of BCG Cell Wall Cytoskeleton on a Dengue Virus-2 Subunit Vaccine
por: Jearanaiwitayakul, Tuksin, et al.
Publicado: (2023)

Cytotoxic activity in culture filtrates from the entomopathogenic fungus Beauveria sulfurescens
por: Mollier, P., et al.
Publicado: (1994)

BCG Aortitis, a Rare Complication of BCG Therapy
por: Haddad, Joseph, et al.
Publicado: (2023)

Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis
por: Del Giudice, Francesco, et al.
Publicado: (2022)

Effect of BCG on cell-mediated cytotoxicity and serum blocking factor during growth of rat hepatoma.
por: Embleton, M. J.
Publicado: (1976)

Immunogenic Properties of a BCG Adjuvanted Chitosan Nanoparticle-Based Dengue Vaccine in Human Dendritic Cells
por: Hunsawong, Taweewun, et al.
Publicado: (2015)

BCG strain S4-Jena: An early BCG strain is capable to reduce the proliferation of bladder cancer cells by induction of apoptosis
por: Schwarzer, Katja, et al.
Publicado: (2010)

BCG Vaccination
Publicado: (1989)

BCG Vaccination
por: Miller, Russell
Publicado: (1953)

BCG orchitis
por: Cutrone, Joseph, et al.
Publicado: (2019)

The BCG Shortage
por: Messing, Edward M.
Publicado: (2017)

Identification of Secreted O-Mannosylated Proteins From BCG and Characterization of Immunodominant Antigens BCG_0470 and BCG_0980
por: Deng, Guoying, et al.
Publicado: (2020)

Vaccination with BCGΔBCG1419c protects against pulmonary and extrapulmonary TB and is safer than BCG
por: Aceves-Sánchez, Michel de Jesús, et al.
Publicado: (2021)

A solitary pulmonary nodule caused by Mycobacterium tuberculosis var. BCG after intravesical BCG treatment: a case report
por: Itai, Mariko, et al.
Publicado: (2021)

P02-08. Enhancement of HIV-1 DNA vaccine immunogenicity by BCG-PSN, a novel adjuvant
por: Sun, J, et al.
Publicado: (2009)

NOD2/RIG-I Activating Inarigivir Adjuvant Enhances the Efficacy of BCG Vaccine Against Tuberculosis in Mice
por: Khan, Arshad, et al.
Publicado: (2020)

Self-adjuvanting nanovaccines boost lung-resident CD4(+) T cell immune responses in BCG-primed mice
por: Files, Megan A., et al.
Publicado: (2022)

BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301)
por: Hayne, Dickon, et al.
Publicado: (2015)

Genome sequences of BCG Pasteur ATCC 35734 and its derivative, the vaccine candidate BCGΔBCG1419c
por: D’Auria, Giuseppe, et al.
Publicado: (2023)

Preoperative estimated glomerular filtration rate as a significant predictor of long-term outcomes after coronary artery bypass grafting in Japanese patients
por: Domoto, Satoru, et al.
Publicado: (2013)

BCG coverage and barriers to BCG vaccination in Guinea-Bissau: an observational study
por: Thysen, Sanne Marie, et al.
Publicado: (2014)

Systemic BCG‐osis following intravesical BCG instillation for bladder carcinoma
por: Liaw, Frank, et al.
Publicado: (2017)

Protective effects of butein on corticosterone-induced cytotoxicity in Neuro2A cells
por: Ohmoto, Masanori, et al.
Publicado: (2020)

Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis
por: Ravindran, Rajesh, et al.
Publicado: (2010)

Recombinant BCG expressing the LTAK63 adjuvant induces increased early and long-term immune responses against Mycobacteria
por: Carvalho Dos Santos, Carina, et al.
Publicado: (2019)

Enhanced immunogenicity of the tuberculosis subunit Rv0572c vaccine delivered in DMT liposome adjuvant as a BCG-booster
por: Mao, Lirong, et al.
Publicado: (2022)

Cyclic di-AMP as endogenous adjuvant enhanced BCG-induced trained immunity and protection against Mycobacterium tuberculosis in mice
por: Ning, Huanhuan, et al.
Publicado: (2022)

Recombinant BCG expressing the LTAK63 adjuvant improves a short-term chemotherapy schedule in the control of tuberculosis in mice
por: Trentini, Monalisa Martins, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nn7v71dsk71kss5cg61bvnk3d5